2018
- BREAKING NEWS: Roche/Genentech Announces US Locations of GENERATION-HD1 Drug Study
- HDSA’s 2018 Research Report Now Available
- EJ Garner Appointed as Chair of HDSA’s National Board of Trustees
- HDBUZZ: Advances on many fronts in the battle against the protein that causes Huntington’s disease
- Genentech/Roche Announces US & Canadian Locations of Observational Natural History Study
- HDSA Awards Five HD Human Biology Project Fellowships for 2018
- FAQs: Upcoming Genentech/Roche Studies
- HDBuzz: Kids Get Huntington’s Disease Too
- RESEARCH WEBINAR: Update from Roche/Genentech on GENERATION-HD1 & RG6042
- HDBuzz: The GENERATION-HD1 trial will test whether RG6042 – formerly Ionis-HTTRx – slows the progression of Huntington’s disease
- Update on RG6042 (formerly known as IONIS-HTTRx) Huntington’s disease global development programme: Two clinical studies to begin by end of 2018
- Roche’s Phase 3 Trial for RG6042 (formerly IONIS HTT-Rx) has been announced: GENERATION-HD1
- Roche Media Release Regarding PRIME Designation Granted by European Medicines Agency for RG6042 (formerly IONIS-HTT Rx)
- IONIS-HTT Rx (RG6042) Granted PRIME Designation by the European Medicines Agency for the Treatment of People with Huntington’s Disease
- Now Accepting 2019 HDSA Centers of Excellence Letters of Interest
- HDBUZZ: First Dolly, now Piglet; a new Huntington’s disease pig knock-in model confirmed
- VIDEO: 33rd Annual HDSA Convention Recap
- 33rd Annual HDSA Convention Recap
- VIDEO: HD Buzz at the 33rd Annual HDSA Convention
- VIDEO: 33rd Annual HDSA Convention Research Forum
- VIDEO: 33rd Annual HDSA Convention Opening Ceremony
- Getting to know Roche & Genentech, RG6042 (formerly known as IONIS-HTTRx )
- HDSA Awards Berman-Topper Family HD Career Development Fellowship
- FAQs Regarding the Latest Huntingtin-Lowering Update from Ionis & Roche
- New Data from IONIS-HTT Rx Phase 1/2 Study Demonstrates Correlation Between Reduction of Disease-causing Protein and Improvement in Clinical Measures of Huntington’s Disease
- HDSA Announces Winners of 2018 Donald A. King Summer Research Fellowship
- Roche Community Statement Regarding RG6042 (formerly known as IONIS-HTTRx )
- HDBuzz: Exciting Experiments in “Open Science” by Huntington’s Researchers
- VIDEO: Postcard from CHDI Meetings in Palm Springs & Malta
- HDSA Partners with the ALS Association & Teva Pharmaceuticals to Identify Novel Therapeutic Targets for CNS Disorders
- HDSA Earns Second Consecutive 4-Star Rating from Charity Navigator
- HDBUZZ: Huntington’s disease therapeutics conference 2018 – day 3
- IONIS-HTT Rx Community Statement
- IONIS-HTT Rx : Top-Line Data Demonstrate Significant Reductions of Disease-Causing Mutant Huntingtin Protein in People with Huntington’s Disease
- HDBUZZ: Huntington’s disease therapeutics conference 2018 – day 2
- HDBUZZ- Huntington’s disease therapeutics conference 2018 – day 1
- HDSA Announces Forty-Three Centers of Excellence
- CEO Memo: Chorea Medication Co-Pay Assistance Programs Information
